Atul Dhir is the Chairman of New Century Health (NCH), joining NCH in January 2012. Dr. Dhir is a physician and scientist with over 25 years of leadership experience in building and leading innovative healthcare companies. Before joining New Century Health, Dr. Dhir was the CEO of BiPar Sciences, Inc., a cancer-focused biotech subsidiary of the global pharmaceutical company, Sanofi-Aventis. Prior to BiPar Sciences, Dr. Dhir was at US Oncology, (now McKesson Specialty Health), one of the largest providers of cancer care in the United States. During his 8 years with US Oncology, Dr. Dhir led several businesses, including serving as the President of the company’s Cancer Research Group, one of the nation’s leading cancer drug development companies. Dr. Dhir has also held senior positions in the health care division of Monsanto Company and as a consultant at McKinsey & Company. Dr. Dhir received his medical degree from the All India Institute of Medical Sciences in New Delhi, India. He completed his doctorate of philosophy (DPhil) in medicine from the University of Oxford, UK, where he studied as a Rhodes Scholar.
Atul Dhir, MD, DPhil
Chairman of New Century Health